First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
The safety and efficacy of AK1320 MS will be evaluated in patients with degenerative
spondylolisthesis and concomitant symptomatic spinal stenosis who are undergoing
decompression and single level instrumented posterolateral lumber autograft fusion surgery.